Motif ID: Epas1_Bcl3
Z-value: 1.651
Transcription factors associated with Epas1_Bcl3:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Bcl3 | ENSMUSG00000053175.10 | Bcl3 |
Epas1 | ENSMUSG00000024140.9 | Epas1 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Epas1 | mm10_v2_chr17_+_86753900_86753914 | 0.71 | 3.7e-06 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.9 | GO:0038095 | positive regulation of mast cell cytokine production(GO:0032765) Fc-epsilon receptor signaling pathway(GO:0038095) |
2.2 | 13.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.6 | 6.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
1.6 | 4.7 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
1.4 | 4.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
1.3 | 9.3 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.2 | 7.5 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
1.1 | 5.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
1.1 | 6.3 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
0.9 | 3.8 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.9 | 9.3 | GO:0071435 | potassium ion export(GO:0071435) |
0.8 | 4.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.8 | 2.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.8 | 4.6 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.8 | 4.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.7 | 2.2 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.7 | 4.4 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.7 | 4.3 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.7 | 1.3 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.7 | 5.2 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.6 | 5.0 | GO:0032264 | IMP salvage(GO:0032264) |
0.6 | 2.5 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.6 | 3.0 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.6 | 2.9 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.6 | 1.7 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.6 | 2.8 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.6 | 12.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.5 | 2.2 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.5 | 4.8 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.5 | 3.6 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.5 | 2.6 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.5 | 1.6 | GO:0048686 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
0.5 | 4.0 | GO:0097264 | self proteolysis(GO:0097264) |
0.5 | 2.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.5 | 2.4 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.4 | 1.3 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.4 | 1.7 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.4 | 6.3 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.4 | 5.1 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.4 | 0.8 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.4 | 4.6 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.4 | 1.1 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.4 | 2.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.4 | 3.5 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.3 | 3.4 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.3 | 2.4 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.3 | 1.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.3 | 3.1 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.3 | 0.9 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.3 | 0.9 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.3 | 2.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.3 | 4.4 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.3 | 5.7 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.3 | 1.9 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.3 | 3.2 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.3 | 1.1 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.3 | 2.6 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.3 | 5.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.3 | 8.1 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.2 | 0.7 | GO:0098528 | terpenoid catabolic process(GO:0016115) skeletal muscle fiber differentiation(GO:0098528) |
0.2 | 0.7 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.2 | 1.0 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.2 | 0.6 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.2 | 7.4 | GO:0060074 | synapse maturation(GO:0060074) |
0.2 | 1.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 1.0 | GO:0021856 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) substrate-dependent cerebral cortex tangential migration(GO:0021825) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
0.2 | 3.1 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.2 | 2.6 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.2 | 0.9 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 1.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.2 | 6.5 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.2 | 2.9 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 1.4 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 1.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 1.0 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 2.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 3.1 | GO:0097178 | ruffle assembly(GO:0097178) |
0.1 | 3.1 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.1 | 0.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.3 | GO:1902277 | negative regulation of pancreatic amylase secretion(GO:1902277) |
0.1 | 1.6 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.4 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 10.6 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.1 | 2.3 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 6.7 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 10.9 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.1 | 4.1 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.7 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.3 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.1 | 0.4 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.1 | 1.8 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.2 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.1 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 3.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.7 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 1.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 2.8 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 1.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.6 | GO:0036506 | maintenance of unfolded protein(GO:0036506) protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 4.8 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 1.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 3.2 | GO:0008542 | visual learning(GO:0008542) |
0.1 | 0.3 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
0.1 | 0.9 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.2 | GO:0070560 | calcium-mediated signaling using extracellular calcium source(GO:0035585) protein secretion by platelet(GO:0070560) positive regulation of platelet aggregation(GO:1901731) |
0.1 | 0.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 1.4 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.1 | 0.6 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 2.2 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.1 | 0.3 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 1.5 | GO:0034340 | response to type I interferon(GO:0034340) |
0.1 | 0.8 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 0.2 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.0 | 0.4 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.0 | 1.5 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.0 | 2.0 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.5 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.7 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.1 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.0 | 5.9 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.0 | 2.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.2 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 4.5 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.0 | 3.5 | GO:0006165 | nucleoside diphosphate phosphorylation(GO:0006165) |
0.0 | 0.3 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.0 | 0.8 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.0 | 0.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.0 | 0.1 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.0 | 0.7 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.4 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.1 | GO:0030070 | insulin processing(GO:0030070) |
0.0 | 1.5 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.0 | 0.3 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.0 | 1.0 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 1.4 | GO:0098792 | xenophagy(GO:0098792) |
0.0 | 0.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.3 | GO:0035036 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
0.0 | 6.4 | GO:0006397 | mRNA processing(GO:0006397) |
0.0 | 0.7 | GO:0051298 | centrosome duplication(GO:0051298) |
0.0 | 0.2 | GO:0032402 | melanosome transport(GO:0032402) |
0.0 | 0.5 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.0 | 0.5 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.3 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.0 | 1.3 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.4 | GO:0000266 | mitochondrial fission(GO:0000266) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 10.9 | GO:0071953 | elastic fiber(GO:0071953) |
2.1 | 6.3 | GO:0043512 | inhibin A complex(GO:0043512) |
1.2 | 23.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
1.1 | 4.4 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.0 | 5.2 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.9 | 1.7 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.8 | 4.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.7 | 4.4 | GO:0008091 | spectrin(GO:0008091) |
0.5 | 4.8 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.5 | 6.4 | GO:0097449 | astrocyte projection(GO:0097449) |
0.5 | 1.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.4 | 1.2 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.4 | 1.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.4 | 5.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 9.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 2.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 1.4 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 4.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 3.6 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 2.4 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.2 | 4.8 | GO:0031430 | M band(GO:0031430) |
0.2 | 3.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 2.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 0.8 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.2 | 4.5 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.4 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.4 | GO:0034679 | integrin alpha2-beta1 complex(GO:0034666) integrin alpha3-beta1 complex(GO:0034667) integrin alpha9-beta1 complex(GO:0034679) |
0.1 | 1.9 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.7 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 6.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 4.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 2.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 3.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 11.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.4 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 2.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.2 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 1.1 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 2.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.6 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 11.9 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 13.5 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) platelet dense tubular network membrane(GO:0031095) |
0.1 | 1.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 4.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.7 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 3.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 2.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 11.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 2.1 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 3.5 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 1.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 8.0 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 6.0 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 1.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 1.6 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 1.9 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.3 | GO:0098793 | presynapse(GO:0098793) |
0.0 | 0.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.6 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 0.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.7 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.7 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 1.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 2.2 | GO:0030054 | cell junction(GO:0030054) |
0.0 | 1.4 | GO:0009986 | cell surface(GO:0009986) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 16.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.9 | 9.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.8 | 5.3 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
1.6 | 6.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.6 | 6.4 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
1.4 | 4.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
1.2 | 7.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
1.1 | 4.5 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.9 | 5.7 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.9 | 2.8 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) glycoprotein transporter activity(GO:0034437) |
0.9 | 5.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.8 | 2.3 | GO:0031752 | D3 dopamine receptor binding(GO:0031750) D5 dopamine receptor binding(GO:0031752) |
0.8 | 3.8 | GO:0055100 | adiponectin binding(GO:0055100) |
0.7 | 5.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.7 | 3.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.7 | 6.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.6 | 6.7 | GO:0016151 | nickel cation binding(GO:0016151) |
0.6 | 4.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.5 | 8.6 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.5 | 2.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.5 | 2.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.4 | 1.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.4 | 9.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.4 | 1.7 | GO:0098988 | PLC activating G-protein coupled glutamate receptor activity(GO:0001639) G-protein coupled glutamate receptor activity(GO:0098988) |
0.4 | 4.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.4 | 3.6 | GO:0034046 | poly(G) binding(GO:0034046) |
0.4 | 1.5 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.4 | 7.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.3 | 1.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.3 | 2.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 2.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.3 | 1.4 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.2 | 6.2 | GO:0005272 | sodium channel activity(GO:0005272) |
0.2 | 1.0 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.2 | 0.9 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.2 | 10.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 0.6 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 2.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 0.6 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 1.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 4.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 1.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 10.8 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 0.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 1.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 1.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 6.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 1.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 4.7 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.6 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.1 | 3.6 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 5.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 1.8 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 2.4 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 4.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 3.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 2.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 2.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 3.1 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.3 | GO:0030249 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.4 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.8 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 2.7 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 1.7 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 3.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 9.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 3.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 2.6 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 2.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 1.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 2.3 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 3.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.3 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.0 | 0.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 1.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 2.7 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 1.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 1.8 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 1.1 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 1.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.6 | GO:0070628 | proteasome binding(GO:0070628) ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) IgG receptor activity(GO:0019770) |
0.0 | 3.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.6 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.3 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.0 | 0.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 3.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 1.6 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.0 | 1.0 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 1.9 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |